Tracking Progress: Weight Loss and Health Improvements Patients undergoing GLP-1 therapy often experience gradual and sustained weight loss
Notably, research indicates that individuals most interested in trying GLP-1 medications, and willing to accept common side effects, are those who report greater body shame, body surveillance, weight concerns, anti-fat bias, disordered eating behaviors, and higher BMIs, alongside lower body appreciation and body neutrality (Markey et al., 2025)
Comparison of the kinetic parameters revealed that ScGrx7 has two distinct glutathione interaction sites
A glutathione transferase from Agrobacterium tumefaciens reveals a novel class of bacterial GST superfamily
Patient-specific compounded GLP-1 medications offer greater dosing flexibility and highly individualized care